Cardiovascular Effects of Apelin In Healthy Volunteers

NCT02259686 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: Apelin 1mg subcutaneous
DRUG: Apelin 1mg intravenous
DRUG: Apelin 5mg subcutaneous
DRUG: Apelin 5mg intravenous
DRUG: Apelin 10 mg subcutaneous

Sponsor

University of Edinburgh

Collaborators

[object Object]